Go to:
Logótipo
Você está em: Start » Publications » View » Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
Publication

Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature

Title
Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclature
Type
Another Publication in an International Scientific Journal
Year
2018
Authors
Bender, JK
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Cattoir, V
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Hegstad, K
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Sadowy, E
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Coque, TM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Westh, H
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Hammerum, AM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Schaffer, K
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Burns, K
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Murchan, S
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Freitas, AR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Peixe, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Del Grosso, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pantosti, A
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Werner, G
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 40
Pages: 25-39
ISSN: 1368-7646
Publisher: Elsevier
Other information
Authenticus ID: P-00P-WAV
Abstract (EN): Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptides often fail. In vitro, most VRE remain susceptible to last-resort antibiotics such as linezolid, tigecycline and daptomycin. However, neither tigecycline nor linezolid act in a bactericidal manner, and daptomycin has proven activity only at high dosages licensed for treating enterococcal endocarditis. Despite these pharmacological and therapeutic limitations, reports on resistance to these last -resort drugs in VRE, and enterococci in general, have increased in recent years. In this review, we briefly recapitulate the current knowledge on the mode of action as well as the known and novel mechanisms of resistance and describe surveillance data on resistance to linezolid, tigecycline and daptomycin in enterococci. In addition, we also suggest a common nomenclature for designating enterococci and VRE with resistances to these important last-resort antibiotics.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 15
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same journal

The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells (2022)
Another Publication in an International Scientific Journal
Xavier, CPR; Belisario, DC; Rebelo, R; Assaraf, YG; Giovannetti, E; Kopecka, J; Helena Vasconcelos, MH
The multi-factorial nature of clinical multidrug resistance in cancer (2019)
Another Publication in an International Scientific Journal
Assaraf, YG; Brozovic, A; Goncalves, AC; Jurkovicova, D; Line, A; Machuqueiro, M; Saponara, S; Sarmento Ribeiro, AB; Xavier, CPR; Helena Vasconcelos, MH
Mechanisms of cisplatin resistance and targeting of cancer stem cells: Adding glycosylation to the equation (2016)
Another Publication in an International Scientific Journal
Ferreira, JA; Peixoto, A; Neves, M; Gaiteiro, C; Celso Reis; Assaraf, YG; Santos, LL
Impact of cancer metabolism on therapy resistance - Clinical implications (2021)
Another Publication in an International Scientific Journal
Goncalves, AC; Richiardone, E; Jorge, J; Polonia, B; Xavier, CPR; Salaroglio, IC; Riganti, C; Helena Vasconcelos, MH; Corbet, C; Sarmento Ribeiro, AB
Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance (2019)
Another Publication in an International Scientific Journal
Helena Vasconcelos, MH; Caires, HR; Abols, A; Xavier, CPR; Line, A

See all (7)

Recommend this page Top
Copyright 1996-2024 © Faculdade de Medicina da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z  I Guest Book
Page created on: 2024-10-05 at 13:27:08
Acceptable Use Policy | Data Protection Policy | Complaint Portal | Política de Captação e Difusão da Imagem Pessoal em Suporte Digital